Stockscreener 앱 받기
2.69
6.27%
-0.18
시간 외 거래:
2.69
전일 마감가:
$2.87
열려 있는:
$2.85
하루 거래량:
294.09K
Relative Volume:
0.07
시가총액:
$12.32M
수익:
$79,300
순이익/손실:
$-6.92M
주가수익비율:
-4.215
EPS:
-0.6382
순현금흐름:
$-5.34M
1주 성능:
-10.03%
1개월 성능:
+26.29%
6개월 성능:
+220.24%
1년 성능:
+647.22%
1일 변동 폭
$2.68
$2.93
1주일 범위:
$2.40
$3.5494
52주 변동 폭
$0.1299
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Virax Biolabs Group Ltd 주식(VRAX)의 최신 뉴스
Virax Biolabs Group Ltd (VRAX)’s Day in Review: Closing at 2.84, Up by 9.65 - The Dwinnex
Virax Biolabs Group Ltd Inc. (VRAX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
A closer look at VRAX’s price-to-free cash flow ratio - US Post News
Virax Biolabs expands Mpox test kit distribution in GCC - Investing.com India
Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar - Lelezard
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. - Benzinga
Ratios Reveal: Breaking Down Virax Biolabs Group Ltd (VRAX)’s Financial Health - The Dwinnex
VRAX’s 2023 Market Dance: Up 140.41% – Time to Invest? - The InvestChronicle
Investing in Virax Biolabs Group Ltd (VRAX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Closing Figures Unveiled: Virax Biolabs Group Ltd (VRAX) Drop -12.90, Closes at 3.51 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) requires closer examination - US Post News
Post-Trade Analysis: Virax Biolabs Group Ltd (VRAX) Slides -7.91, Closing at 4.66 - The Dwinnex
Virax Biolabs Group Ltd (VRAX) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Luminar Technologies Inc (NASDAQ: LAZR) Shares Look Bullish In 2024 - Stocks Register
NuCana halts NuTide:323 study on colorectal cancer - Investing.com
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com Australia
NuCana halts NuTide:323 study on colorectal cancer By Investing.com - Investing.com UK
Virax Biolabs to Participate at 7th European Congress of Immunology - Quantisnow
Wall Street-Heavily Traded - WDRB
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - LongPort
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN
Russia bans entry to dozens of American journalists, including WSJ, NYT and Washington Post - CNN International
Virax stock soars on Mpox tests deal in Europe and Middle East - Invezz
Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - TradingView
Virax Biolabs expands Mpox test kit distribution in Europe, GCC By Investing.com - Investing.com Australia
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East - Yahoo Finance
Virax Biolabs signs distribution agreement for Mpox virus detection kits - TipRanks
Virax Biolabs Group Ltd (VRAX) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
Closing Figures: Virax Biolabs Group Ltd (VRAX)’s Negative Finish at 4.61, Down -15.41 - The Dwinnex
There is no way Virax Biolabs Group Ltd (VRAX) can keep these numbers up - SETE News
Monkeypox Stocks Round 2: Mpox Stocks - Wealth Daily
Virax Biolabs Introduces New Share Purchase Warrant - TipRanks
Pre-market Movers: SQNS, MNTS, UBXG, PRTG, PTWO… - RTTNews
Canadian government forces rail lockout to end - CNN International
Pixie Dust Technologies, Inc. Announces Fiscal Year 2024 Financial Results - Quantisnow
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Fake celebrity endorsements become latest weapon in misinformation wars, sowing confusion ahead of 2024 election - CNN International
Canadian freight railroads shut down, dealing a potential blow to North America’s economy - CNN International
Cosmos Health secures distribution rights for mpox PCR kits - Investing.com India
Judge blocks Arizona lithium drilling that tribe says is threat to sacred lands - 69News WFMZ-TV
Nu Asset FICFII Em Debentures De Infraestrutura Renda Fixa Credito Privado (NUIF11.SA) - Yahoo Finance
Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares - Yahoo Finance
New data shows US job growth has been far weaker than initially reported - CNN International
Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits - Yahoo Finance
Trading Day Review: Virax Biolabs Group Ltd (VRAX) Loses Momentum, Closing at 3.56 - The Dwinnex
How Kamala Harris is winning over Wall Street - CNN International
China to probe European dairy imports as trade dispute escalates - CNN International
Europe just slashed tariffs on cars made by Tesla in China - CNN International
US judge strikes down Biden administration ban on worker ‘noncompete’ agreements - CNN International
Virax Biolabs Group Ltd [VRAX] Revenue clocked in at $0.08 million, up 252.74% YTD: What’s Next? - The DBT News
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions - Yahoo Finance
Virax Biolabs Group Ltd (VRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
1.31%
자본화:
|
볼륨(24시간):